Navigation Links
Cancer requires support from immune system to develop, UT Southwestern researchers report
Date:10/30/2008

gene and one mutated gene develop the disease.

The UT Southwestern researchers had previously found in mice that plexiform neurofibromas develop from Schwann cells that have two mutated copies of Nf1. In addition, they discovered that even before a plexiform neurofibroma begins to form around a nerve, mast cells migrate into the area.

In the current study, the scientists used genetically engineered mice to confirm first that the animals need two mutated copies of Nf1 in their Schwann cells to develop neurofibromas, which the rest of their cells can still have one normal and one mutant Nf1 gene.

In addition, a bone marrow transplant from normal mice with two normal Nf1 genes prevented 90 percent of the engineered mice from developing neurofibromas, confirming that even with two mutated genes in the Schwann cells, a mutated copy must also be present in other cells. Bone marrow is the source of mast cells, blood cells and many other types of cells that circulate through blood vessels.

The researchers then focused on the role of mast cells in tumor formation, particularly a molecule on the cells' surface called c-kit, which controls many functions, including migration and proliferation.

The mice engineered to develop tumors were given the drug imatinib mesylate, also known as Gleevec. The drug, known to inhibit c-kit, currently is used to treat chronic myelogenous leukemia and other cancers.

Positron emission tomography scans showed that Gleevec halved the metabolic activity of the tumors, while later examination confirmed that the tumors were much smaller than in placebo-treated mice.

"We found there was a requirement from the immune system to interact with the tumor for the tumor to grow," Dr. Parada said. "When mast cells are blocked, the tumor cannot grow."

During the course of these experiments, the researchers learned about a girl who had a large neurofibroma that could not be removed s
'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer requires support from immune system to develop, UT Southwestern researchers report
Cancer requires support from immune system to develop, UT Southwestern researchers report
Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 1U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 2U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 3U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 4Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 1Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 1WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 3WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 4